Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Dec 2021 Toxins The Cytotoxic Necrotizing Factors (CNFs)-A Family of Rho GTPase-Activating Bacterial Exotoxins Autoren Chaoprasid P Dersch P Dec 2021 NPJ Prim Care Resp Med Acute respiratory infections in an adult refugee population: an observational study Autoren Jablonka A et al. Dec 2021 J Virol Catch me if you can - the crosstalk of ZIKV and the restriction factor Tetherin Autoren Herrlein ML et al. Dec 2021 Nature Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta Autoren Ulrich L et al. Dec 2021 Pathogens Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General Autoren Pischke S et al. Dec 2021 Viruses αVβ3 Integrin Expression Is Essential for Replication of Mosquito and Tick-Borne Flaviviruses in Murine Fibroblast Cells Autoren Reis VPD et al. Dec 2021 Antimicrob Agents Chemother Bloodstream infections caused by Magnusiomyces capitatus and Magnusiomyces clavatus: epidemiological, clinical and microbiological features of two emerging yeast species Autoren Noster J et al. Dec 2021 Cell Rep Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses Autoren Wratil PR et al. Dec 2021 medRxiv mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al. Dec 2021 Trop Med Infect Dis Pilot Malacology Surveys for the Intermediate Hosts of Schistosomiasis in Rural and Semi-Urban Areas of the Moyen-Ogooué Province, Gabon Autoren Agobé JCD et al. Dec 2021 PLoS Negl Trop Dis TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature Autoren Nordmann T et al. Dec 2021 PLoS One Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors Autoren Hamann MV et al. Dec 2021 Front Cell Infect Microbiol Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections? Autoren Schlatterer K Peschel A Kretschmer D Dec 2021 Nucleic Acids Res Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread Autoren Ambike S et al. Dec 2021 Front Immunol Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 Autoren Mellinghoff SC et al. Dec 2021 Clin Microbiol Infect European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine) Autoren Paul M et al. Dec 2021 Cell The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic Autoren Hoffmann M et al. Dec 2021 Ann Clin Microb Antimicrob Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients Autoren Elion Assiana DO et al. Dec 2021 Clin Immunol Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants Autoren Hargreaves CE et al. Dec 2021 BMJ Open Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling Autoren Lorenz E et al. Dec 2021 J Infect T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option Autoren Mellinghoff SC et al. Dec 2021 Cell Host Microbe Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers Autoren Vanshylla K et al. Dec 2021 JHEP Rep Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality Autoren Reißing J et al. Dec 2021 J Allergy Clin Immunol Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency Autoren Yang L et al. Dec 2021 J Intern Med Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100 Autoren Plochg BFJ et al. Pagination Previous page ‹‹ Seite 1 Current page 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Next page ››
Dec 2021 Toxins The Cytotoxic Necrotizing Factors (CNFs)-A Family of Rho GTPase-Activating Bacterial Exotoxins Autoren Chaoprasid P Dersch P
Dec 2021 NPJ Prim Care Resp Med Acute respiratory infections in an adult refugee population: an observational study Autoren Jablonka A et al.
Dec 2021 J Virol Catch me if you can - the crosstalk of ZIKV and the restriction factor Tetherin Autoren Herrlein ML et al.
Dec 2021 Nature Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta Autoren Ulrich L et al.
Dec 2021 Pathogens Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General Autoren Pischke S et al.
Dec 2021 Viruses αVβ3 Integrin Expression Is Essential for Replication of Mosquito and Tick-Borne Flaviviruses in Murine Fibroblast Cells Autoren Reis VPD et al.
Dec 2021 Antimicrob Agents Chemother Bloodstream infections caused by Magnusiomyces capitatus and Magnusiomyces clavatus: epidemiological, clinical and microbiological features of two emerging yeast species Autoren Noster J et al.
Dec 2021 Cell Rep Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses Autoren Wratil PR et al.
Dec 2021 medRxiv mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al.
Dec 2021 Trop Med Infect Dis Pilot Malacology Surveys for the Intermediate Hosts of Schistosomiasis in Rural and Semi-Urban Areas of the Moyen-Ogooué Province, Gabon Autoren Agobé JCD et al.
Dec 2021 PLoS Negl Trop Dis TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature Autoren Nordmann T et al.
Dec 2021 PLoS One Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors Autoren Hamann MV et al.
Dec 2021 Front Cell Infect Microbiol Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections? Autoren Schlatterer K Peschel A Kretschmer D
Dec 2021 Nucleic Acids Res Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread Autoren Ambike S et al.
Dec 2021 Front Immunol Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19 Autoren Mellinghoff SC et al.
Dec 2021 Clin Microbiol Infect European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine) Autoren Paul M et al.
Dec 2021 Cell The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic Autoren Hoffmann M et al.
Dec 2021 Ann Clin Microb Antimicrob Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients Autoren Elion Assiana DO et al.
Dec 2021 Clin Immunol Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants Autoren Hargreaves CE et al.
Dec 2021 BMJ Open Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling Autoren Lorenz E et al.
Dec 2021 J Infect T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option Autoren Mellinghoff SC et al.
Dec 2021 Cell Host Microbe Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers Autoren Vanshylla K et al.
Dec 2021 JHEP Rep Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality Autoren Reißing J et al.
Dec 2021 J Allergy Clin Immunol Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency Autoren Yang L et al.
Dec 2021 J Intern Med Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100 Autoren Plochg BFJ et al.
